House Republicans introduce plan to delay ACA taxes

The Affordable Care Act’s taxes on health insurance, high-cost health plans and medical devices would be delayed under a series of bills introduced by House Republicans, with the Medical Imaging & Technology Alliance (MITA) quickly coming out in support of suspending the device tax.

The pieces of legislation introduced by Republican members of the House Ways and Means Committee would:

  • Delay the 2.3 percent tax on medical devices for five years.
  • Delay the health insurance tax for two years, though in 2018 it would require insurers to offer a rebate on premiums to customers.
  • Delay the health insurance tax for two years for plans regulated by Puerto Rico.
  • Delay the 40 percent “Cadillac tax” on high-cost health plans by one year.
  • Eliminate penalties for employers who don’t offer health insurance in 2018, along with three years of retroactive relief.

“Obamacare’s failures are continuing to hurt families across the country—and allowing burdensome health care taxes to continue or go back into effect would make these problems even more severe,” House Ways and Means chairman Kevin Brady, R-Texas, said in a statement. “As we continue working toward a patient-centered health care system, Ways and Means Republicans are taking action to provide targeted relief from taxes that stand in the way of affordable health care, innovative treatments, access to medications, more jobs, and bigger paychecks for hardworking Americans.”

The ”Cadillac tax” in particular has been a controversial and frequently targeted measure of the ACA, even among Democrats. The tax has never taken effect, with some Democrats supporting a previous measure to delay its implementation until 2020.

The 2.3 percent medical device tax has also been delayed before, but that suspension period is set to end on Dec. 3. A five-year delay is “a step in the right direction” toward getting rid of it altogether, according to MITA.

“Allowing the device tax to restart in 2018, even temporarily, would amount to a tax hike on the industry and could result in job loss as well as disruptions to the medical imaging industry’s ability to innovate,” Patrick Hope, MITA’s executive director, said in a statement. “Ultimately, we hope that Congress will continue to work toward full repeal of the medical device tax to safeguard high-paying, high-quality industry jobs and ensure that patients have access to the latest medical imaging technology.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.